Logo AIPTO TechBio

AIPTO TechBio

  • Startup
  • Pharmaceutical Sector, Chemical Industry, Biotech

Company information

AIPTO TechBio is a spin-off of the German Cancer Research Center (DKFZ) based in Basel. The company utilizes patient-derived tumor models combined with generative AI to enhance the prediction of individual therapy responses and support personalized cancer treatments. The focus is initially on developing solutions for brain cancer.

Technologies

Topics we work on

  • AI
  • Machine Learning
  • HealthTech